NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 36 filers reported holding NRX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,507 | -50.2% | 9,644 | -7.3% | 0.00% | – |
Q2 2023 | $5,031 | -31.5% | 10,407 | -6.6% | 0.00% | – |
Q1 2023 | $7,343 | -58.2% | 11,141 | -29.6% | 0.00% | – |
Q4 2022 | $17,567 | +3.3% | 15,827 | -34.8% | 0.00% | – |
Q3 2022 | $17,000 | +6.2% | 24,273 | -13.4% | 0.00% | – |
Q2 2022 | $16,000 | -81.0% | 28,013 | -18.5% | 0.00% | -100.0% |
Q1 2022 | $84,000 | -52.5% | 34,388 | -7.3% | 0.00% | -50.0% |
Q4 2021 | $177,000 | -55.1% | 37,105 | -12.8% | 0.00% | -33.3% |
Q3 2021 | $394,000 | +74.3% | 42,568 | +118.4% | 0.00% | +50.0% |
Q2 2021 | $226,000 | – | 19,490 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Texas Capital Bank Wealth Management Services Inc | 63,290 | $41,714 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 230,700 | $152,054 | 0.00% |
Virtu Financial LLC | 46,210 | $30 | 0.00% |
United Asset Strategies, Inc. | 18,300 | $12,062 | 0.00% |
HBK Sorce Advisory LLC | 29,230 | $19,266 | 0.00% |
UBS Group AG | 18,611 | $12,265 | 0.00% |
NewEdge Advisors, LLC | 2,125 | $1,401 | 0.00% |
OSAIC HOLDINGS, INC. | 27,225 | $17,933 | 0.00% |
BANK OF AMERICA CORP /DE/ | 30,000 | $19,770 | 0.00% |
WELLS FARGO & COMPANY/MN | 5,309 | $3,500 | 0.00% |